Mechanism of action of the hypnotic zolpidem in vivo.

Article Details

Citation

Copy to clipboard

Crestani F, Martin JR, Mohler H, Rudolph U

Mechanism of action of the hypnotic zolpidem in vivo.

Br J Pharmacol. 2000 Dec;131(7):1251-4. doi: 10.1038/sj.bjp.0703717.

PubMed ID

11090095 [ View in PubMed

]

Abstract

Zolpidem is a widely used hypnotic agent acting at the GABA(A) receptor benzodiazepine site. On recombinant receptors, zolpidem displays a high affinity to alpha 1-GABA(A) receptors, an intermediate affinity to alpha(2)- and alpha(3)-GABA(A) receptors and fails to bind to alpha(5)-GABA(A) receptors. However, it is not known which receptor subtype is essential for mediating the sedative-hypnotic action in vivo. Studying alpha1(H101R) mice, which possess zolpidem-insensitive alpha(1)-GABA(A) receptors, we show that the sedative action of zolpidem is exclusively mediated by alpha(1)-GABA(A) receptors. Similarly, the activity of zolpidem against pentylenetetrazole-induced tonic convulsions is also completely mediated by alpha(1)-GABA(A) receptors. These results establish that the sedative-hypnotic and anticonvulsant activities of zolpidem are due to its action on alpha(1)-GABA(A) receptors and not on alpha(2)- or alpha(3)-GABA(A) receptors.

DrugBank Data that Cites this Article

Drugs

Zolpidem

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Zolpidem	Gamma-aminobutyric acid receptor subunit alpha-2	Protein	Humans	Unknown	Agonist	Details
Zolpidem	Gamma-aminobutyric acid receptor subunit alpha-3	Protein	Humans	Unknown	Agonist	Details